U.S. flag

An official website of the United States government

NM_000018.4(ACADVL):c.1406G>A (p.Arg469Gln) AND Very long chain acyl-CoA dehydrogenase deficiency

Germline classification:
Pathogenic/Likely pathogenic (3 submissions)
Last evaluated:
Nov 1, 2019
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000169627.5

Allele description

NM_000018.4(ACADVL):c.1406G>A (p.Arg469Gln)

Gene:
ACADVL:acyl-CoA dehydrogenase very long chain [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
17p13.1
Genomic location:
Preferred name:
NM_000018.4(ACADVL):c.1406G>A (p.Arg469Gln)
HGVS:
  • NC_000017.11:g.7224041G>A
  • NG_007975.1:g.9208G>A
  • NG_008391.2:g.1010C>T
  • NG_033038.1:g.15504C>T
  • NM_000018.4:c.1406G>AMANE SELECT
  • NM_001033859.2:c.1340G>A
  • NM_001270447.1:c.1475G>A
  • NM_001270448.1:c.1178G>A
  • NP_000009.1:p.Arg469Gln
  • NP_000009.1:p.Arg469Gln
  • NP_001029031.1:p.Arg447Gln
  • NP_001257376.1:p.Arg492Gln
  • NP_001257377.1:p.Arg393Gln
  • NC_000017.10:g.7127360G>A
  • NM_000018.3:c.1406G>A
  • P49748:p.Arg469Gln
Protein change:
R393Q
Links:
UniProtKB: P49748#VAR_000361; dbSNP: rs398123083
NCBI 1000 Genomes Browser:
rs398123083
Molecular consequence:
  • NM_000018.4:c.1406G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001033859.2:c.1340G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001270447.1:c.1475G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001270448.1:c.1178G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Very long chain acyl-CoA dehydrogenase deficiency (VLCAD)
Synonyms:
VLCAD deficiency
Identifiers:
MONDO: MONDO:0008723; MedGen: C3887523; Orphanet: 26793; OMIM: 201475

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000221156Counsyl
criteria provided, single submitter

(Counsyl Autosomal and X-linked Recessive Disease Classification criteria (2015))
Likely pathogenic
(Feb 25, 2015)
unknownliterature only

PubMed (4)
[See all records that cite these PMIDs]

Counsyl Autosomal and X-linked Recessive Disease Classification criteria (2015),

Citation Link,

SCV001364931Wong Mito Lab, Molecular and Human Genetics, Baylor College of Medicine
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Nov 1, 2019)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

SCV001413446Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Oct 13, 2019)
germlineclinical testing

PubMed (6)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedunknownunknownnot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Muscle MRI in patients with long-chain fatty acid oxidation disorders.

Diekman EF, van der Pol WL, Nievelstein RA, Houten SM, Wijburg FA, Visser G.

J Inherit Metab Dis. 2014 May;37(3):405-13. doi: 10.1007/s10545-013-9666-3. Epub 2013 Dec 5.

PubMed [citation]
PMID:
24305961

Neuropsychological outcomes in fatty acid oxidation disorders: 85 cases detected by newborn screening.

Waisbren SE, Landau Y, Wilson J, Vockley J.

Dev Disabil Res Rev. 2013;17(3):260-8. doi: 10.1002/ddrr.1119.

PubMed [citation]
PMID:
23798014
PMCID:
PMC4137760
See all PubMed Citations (10)

Details of each submission

From Counsyl, SCV000221156.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (4)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

From Wong Mito Lab, Molecular and Human Genetics, Baylor College of Medicine, SCV001364931.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

The NM_000018.3:c.1406G>A (NP_000009.1:p.Arg469Gln) [GRCH38: NC_000017.11:g.7224041G>A] variant in ACADVL gene is interpretated to be Pathogenic based on ACMG guidelines (PMID: 25741868). This variant has been reported in PMID: 9973285. This variant meets the following evidence codes reported in the ACMG guidelines: PS1, PS3

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Invitae, SCV001413446.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (6)

Description

This sequence change replaces arginine with glutamine at codon 469 of the ACADVL protein (p.Arg469Gln). The arginine residue is highly conserved and there is a small physicochemical difference between arginine and glutamine. This variant is not present in population databases (ExAC no frequency). This variant has been observed to be homozygous in an individual affected with very long chain acyl-CoA dehydrogenase deficiency (PMID: 25834949). ClinVar contains an entry for this variant (Variation ID: 92276). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. This variant disrupts the p.Arg469 amino acid residue in ACADVL. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 9973285, 17999356, 27246109, 17374501). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 1, 2021